Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 266,100 shares, a growth of 964.4% from the August 15th total of 25,000 shares. Based on an average daily volume of 21,562,100 shares, the days-to-cover ratio is currently 0.0 days.

Therapeutic Solutions International Price Performance

Shares of TSOI stock remained flat at $0.00 on Thursday. The company had a trading volume of 15,684,532 shares, compared to its average volume of 12,660,273. Therapeutic Solutions International has a 12-month low of $0.00 and a 12-month high of $0.02.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.